Amoebic liver abscess medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 25: Line 25:


Current treatment recommendations of ''[[Entamoeba|E histolytica]]'' includes
Current treatment recommendations of ''[[Entamoeba|E histolytica]]'' includes
* With medical therapy alone, the cure rates of more than 90% have been reported, with the resolution of pain, fever, and anorexia with in 72h to 96h.
{| class="wikitable"
!Treatment phase
!Drug
!Adult
!Pediatric
|-
| rowspan="2" |Initial treatment of amoebic liver abscess
|Metronidazole
|750 mg PO TID × 7–10 days
|35–50 mg/kg/day DIVIDED TID × 7–10 days
|-
|Tinidazole
|2 g once PO daily × 3 days
|>3 years: 50 mg/kg/day (max 2 g) PO in 1 dose × 3 days
|-
| rowspan="2" |Clearance of luminal cysts
|Iodoquinol
|650 mg PO TID × 20 days
|30–40 mg/kg/day DIVIDED TID × 20 days (max 2 g/day)
|-
|Paromomycin
|500 mg PO TID × 7 days OR
25–35 mg/kg/day DIVIDED TID × 7 days
|25–35 mg/kg/day DIVIDED TID × 7 days
|}


Antibiotic treatment
Antibiotic treatment

Revision as of 01:57, 14 February 2017

Liver abscess Main Page

Amoebic liver abscess Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating amoebic liver abscess from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Diagnostic Approach

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amoebic liver abscess medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amoebic liver abscess medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amoebic liver abscess medical therapy

CDC on Amoebic liver abscess medical therapy

Amoebic liver abscess medical therapy in the news

Blogs on Amoebic liver abscess medical therapy

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Amoebic liver abscess medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Medical Therapy

Pharmocotherapy for E histolytica include:

Site Of Infection Treatment
Intraluminal infection Iodoquinol 650mg tid X 20 days
Diloxanide furoate 500mg tid X 20 days
Paramomycin 30mg/kg/day X 10 days (in 3 divided doses)
Amoebic liver abscess Metronidazole 800mg tid PO X 10days (500mg qid IV)
Invasive colitis Metronidazole 800mg tid X 5 days
Tinidazole 1 gm bd X 3 days

Current treatment recommendations of E histolytica includes

  • With medical therapy alone, the cure rates of more than 90% have been reported, with the resolution of pain, fever, and anorexia with in 72h to 96h.
Treatment phase Drug Adult Pediatric
Initial treatment of amoebic liver abscess Metronidazole 750 mg PO TID × 7–10 days 35–50 mg/kg/day DIVIDED TID × 7–10 days
Tinidazole 2 g once PO daily × 3 days >3 years: 50 mg/kg/day (max 2 g) PO in 1 dose × 3 days
Clearance of luminal cysts Iodoquinol 650 mg PO TID × 20 days 30–40 mg/kg/day DIVIDED TID × 20 days (max 2 g/day)
Paromomycin 500 mg PO TID × 7 days OR

25–35 mg/kg/day DIVIDED TID × 7 days

25–35 mg/kg/day DIVIDED TID × 7 days

Antibiotic treatment Invasive therapeutic procedures 1: ultrasound guided needle aspiration, percutaneous catheter drainage, and open surgical abscess drainage

References